Geron price to sales ratio GERN

Market value divided by revenue over the last twelve months, since 2012.

Today, Oct 23, 2026: 3.5×
10-year median: 8.1×
Against its 10-year history: 0th; percentile: 0 is its lowest day, 100 its highest
10-year range: 3.5× to 87.1×
Peer median: 1.5×

Geron's price to sales ratio is 3.5× as of Oct 23, 2026.

That is below its ten-year median of 8.1×, lower than on 100% of days in the last ten years.

Over that time it ranged from 3.5× in Oct 2026 to 87.1× in Nov 2024.

The median for 10 large drugmakers of a similar size is 1.5×.

Price to sales ratio over time

median 8.1×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	3.5×	3.5×	6.5×
2025	4.8×	3.9×	73.2×
2024	68.7×	68.7×	87.1×
2023	n/m a value too high to mean anything
2022	n/m a value too high to mean anything
2021	n/m a value too high to mean anything
2020	n/m a value too high to mean anything
2019	n/m a value too high to mean anything
2018	n/m a value too high to mean anything
2017	57.3×	50.1×	78.8×
2016	52.4×	8.2×	56.4×
2015	n/m a value too high to mean anything
2014	n/m a value too high to mean anything
2013	63.1×	47.8×	91.0×
2012	79.5×	57.6×	194×

Against its peers

Companies in Drug Manufacturers - General nearest Geron's size, closest first, today.

Company	Price to sales ratio
GERNGeron	3.5×
COLLCollegium Pharmaceutical	0.9×
ABUSArbutus Biopharma	4.6×
CRMDCorMedix	1.3×
ZVRAZevra Therapeutics	4.3×
IRWDIronwood Pharmaceuticals	1.5×
PBYIPuma Biotechnology	2.5×
AMPHAmphastar Pharmaceuticals	1.5×
ARVNArvinas	1.5×
OMEROmeros	n/m
PCRXPacira BioSciences	1.9×
Peer median	1.5×

Where Geron ranks

#67of 157Large drugmakers with the lowest price to sales ratio

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on Geron

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.